27
Offering quality of life to patients is another of the objectives of current research. Photo: DM.
2023-05-30 12:39:16
Oncology
–
Reduces administration time and adverse effects, compared to the intravenous route
Reduces administration time and adverse effects, compared to the intravenous route
The combined combination of subcutaneous pertuzumab and trastuzumab offers better quality of life, without affecting safety and oncological efficacy.
1685455904
#subcutaneous #combination #monoclonal #antibodies #lengthens #broadens #quality #life #HER2 #breasts
